Company Quick10K Filing
UR-Energy
10-Q 2021-03-31 Filed 2021-05-07
10-K 2020-12-31 Filed 2021-02-26
10-Q 2020-09-30 Filed 2020-10-30
10-Q 2020-06-30 Filed 2020-08-05
10-Q 2020-03-31 Filed 2020-05-08
10-K 2019-12-31 Filed 2020-02-28
10-Q 2019-09-30 Filed 2019-11-01
10-Q 2019-06-30 Filed 2019-08-02
10-Q 2019-03-31 Filed 2019-05-03
10-K 2018-12-31 Filed 2019-03-01
10-Q 2018-09-30 Filed 2018-10-26
10-Q 2018-06-30 Filed 2018-07-27
10-Q 2018-03-31 Filed 2018-05-04
10-K 2017-12-31 Filed 2018-03-02
10-Q 2017-09-30 Filed 2017-10-27
10-Q 2017-06-30 Filed 2017-07-28
10-Q 2017-03-31 Filed 2017-05-05
10-K 2016-12-31 Filed 2017-03-03
10-Q 2016-09-30 Filed 2016-10-28
10-Q 2016-06-30 Filed 2016-07-29
10-Q 2016-03-31 Filed 2016-05-06
10-K 2015-12-31 Filed 2016-02-26
10-Q 2015-09-30 Filed 2015-10-30
10-Q 2015-06-30 Filed 2015-07-31
10-Q 2015-03-31 Filed 2015-05-04
10-K 2014-12-31 Filed 2015-03-02
10-Q 2014-09-30 Filed 2014-11-03
10-Q 2014-06-30 Filed 2014-08-01
10-Q 2014-03-31 Filed 2014-04-30
10-K 2013-12-31 Filed 2014-03-03
20-F 2009-12-31 Filed 2010-03-12
8-K 2020-10-30
8-K 2020-10-21
8-K 2020-10-06
8-K 2020-08-05
8-K 2020-07-31
8-K 2020-05-29
8-K 2020-05-07
8-K 2020-04-23
8-K 2020-04-16
8-K 2020-02-28
8-K 2019-11-01
8-K 2019-10-01
8-K 2019-08-02
8-K 2019-07-12
8-K 2019-07-11
8-K 2019-05-02
8-K 2019-04-11
8-K 2019-03-07
8-K 2019-03-01
8-K 2019-01-14
8-K 2018-10-26
8-K 2018-10-15
8-K 2018-09-21
8-K 2018-08-07
8-K 2018-07-27
8-K 2018-07-18
8-K 2018-07-12
8-K 2018-05-03
8-K 2018-04-12
8-K 2018-03-30
8-K 2018-03-02
8-K 2018-01-19
8-K 2018-01-16
8-K 2018-01-09

UR-Energy Financials

URG Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Aries I Acquisition Corp. (RAMMU)
024 Pharma (EEIG)
Beauty Health Co (VSPRW)
Aquarius I Acquisition Corp. (AQUI)
MIZUHO FINANCIAL GROUP INC (MZHOF)
Eucrates Biomedical Acquisition Corp. (EUCRW)
11 Good Energy (ELVN)
180 Life Sciences Corp. (ATNFW)
1347 Capital Corp (TFSC)
Avanti Acquisition Corp. (AVAN-WT)
CORDIA CORP (CORG)
FCCC INC (FCIC)
Biofrontera Inc. (BFRI)
Ameren Illinois Co (AILNP)
MITSUBISHI UFJ FINANCIAL GROUP INC (MBFJF)
Janus International Group, Inc. (JBI-WT)
23andMe Holding Co. (MEUSW)
OceanTech Acquisitions I Corp. (OTECU)
Palayan Resources, Inc. (PLYN)
ALABAMA POWER CO (APRCP)

Balance Sheet ($'000)2013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash1,6274,6721,5543,3723,1042,1823,8513,6271,4437,3172,4752,9611,5528,3937,3209,70311,43716,62714,98919,07813,83011,37613,99710,823
Accounts Receivable5,7294,2517,2066,0761952,5243,2917,8851,119
Inventory2,0533,9162,2013,3015,1684,7033,8854,8583,3455,9344,8903,4054,1095,7617,4511,7204,5156,99814,69214,9529,1277,357
PP&E38,88738,91538,93538,96139,07639,10039,11339,08239,06738,93738,76438,76038,77638,78638,91738,94938,85538,89738,90038,90038,90639,00039,11439,149
Assets105,336106,966103,048109,056104,451101,40399,36399,99795,757103,22098,35195,92589,94098,00097,35392,83188,36495,44995,550101,304100,36397,08793,11388,233
Accounts Payable2,9003,8002,8002,6001,5031,6691,0451,3561,4022,5101,0962,4007253,1001,3691,6008401,500642919620608580646
Long-Term Debt39,15340,57739,68842,37540,56738,74626,72826,70733,19323,38328,23326,09324,51422,83621,71920,58519,89118,26817,08315,88114,99613,46112,17112,203
Liabilities66,67269,22165,85774,73472,35070,96967,60768,30563,25667,55564,40260,03953,70854,88152,67050,96549,58349,91247,13147,94048,51649,35947,12546,264
Stockholders' Equity38,66437,74537,19134,32232,10130,43431,75631,69232,50135,66533,94935,88636,23243,11944,68341,86638,78145,53748,41953,36451,84747,72845,98841,969
Income Statement ($'000)2013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue6,1479,2367,3296,6377,38718,2138,4917,7862,7146,74712,0685,77614,82811,82136,5132619,6723,80734,81211,4795,115
Cost of Revenue3,2407,1693,7523,6975,39013,7914,1805,9311,8555,0945,8183,0816,2956,57311,1573769,7582,2251705,14611,1637,515
Gross Profit2,9072,0673,5772,9401,9974,4224,3111,8558591,6536,2502,6958,5335,248536-3509,91410,960-167-334316-2,400
R&D5747113,7382,6491,0295571,9301,8425497271,1085022161,8291,454841432440522166292373
SG&A2,3121,3351,4691,4251,5171,7431,0811,3741,3651,4599729441,7149631,0711,3421,9221,9501,1692,1381,1531,283
Tax
Net Income-1,948-804-3,500-2,497-2,1241,025-287591-2,989-1,9281,8031045,1891,316-3,003-3,4266,41812,012-2,809-4,302-2,031-4,200
Cash Flow ($'000)2013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating1,242-2,252-2483,1956283,4011,624-2831,9053,1567676,514-3,9192,8606,434-4,021-4,050-1,2013,865-3,114
Cash Investing-358-17-1,034-1,599-24-1911-28-12-101-15-10-75-16-603,537-41-19-114-31
Cash Financing2,264-9363,106-1,857-1,520-1,730-1,849-1,8653,715-2,291-2,197343-1,180-1,114-1,169-1,1488,176-1,275-1,153-18